Navigation Links
Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
Date:1/23/2008

a non-small cell lung cancer protocol in combination with carboplatin and paclitaxel. Bavituximab is also in clinical trials in the U.S. in patients with advanced solid tumors and in patients co-infected with HCV and HIV.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to the risk that the company will experience delays or difficulties in enrolling patients in the study, and the risk that the results from this trial will not be consistent with the results of prior trials or preclinical studies. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing
'/>"/>

SOURCE Peregrine Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
3. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
4. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
5. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
6. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
7. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( ... "Medical Device Outsourcing - Global Strategic Business ... This report analyzes the worldwide markets for Medical ... Device Categories: Class I, Class II, and Class ... report Include - Radiology, Orthopedic, Neurology, Cardiology, and ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ... Equipment Rental and Leasing - Global Strategic Business Report" ... analyzes the worldwide markets for Medical Equipment Rental and ... analytics for the US, Japan , ... Annual estimates and forecasts are provided for ...
(Date:4/17/2015)... , April 17, 2015 ASSESS ... mutation   is a viable alternative to tumour biopsy   ... in all patients with advanced NSCLC   AstraZeneca ... of plasma circulating tumour DNA (ctDNA) testing for epidermal growth ... advanced non-small cell lung cancer (NSCLC) in clinical practice. [ ...
Breaking Medicine Technology:Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... 2011 OncologyRx Care Advantage, McKesson Specialty Health ... by Incyte Corporation as one of only ... to fill prescriptions for Jakafi (ruxolitinib), an oral prescription ... (Logo:  http://photos.prnewswire.com/prnh/20110912/DA65711LOGO ) ...
... Solos Endoscopy, Inc.,s (OTCPK: SNDY) is pleased to ... Net Profit of $73,895.  Solos Endoscopy has consummated agreements ... for the Three Months period ending September 30, 2011. ... in a reduction of ongoing expenses by approximately $40,000 ...
Cached Medicine Technology:OncologyRx Care Advantage™ Chosen to Fill Prescriptions for Jakafi™ (ruxolitinib) 2Solos Endoscopy Finishes the 3rd Quarter With a Net Profit 2
(Date:4/19/2015)... Family and friends of Brad Baddeley are ... of Brad Baddeley event to honor his memory and ... for Brains is cheduled to take place on Sunday, April ... Lincoln, Nebraska. Participants may arrive at 12:30pm on the 26th ... cost is only $4 per game and 100% of the ...
(Date:4/18/2015)... Hills, CA (PRWEB) April 19, 2015 For ... and will proudly display for the rest of their lives, ... money obtaining them and put in a great amount of ... on a whim, they have outgrown them or simply want ... percent of people regret their tattoo, and in 2012-13 there ...
(Date:4/18/2015)... 2015 Compare-autoinsurance.org has released a new ... auto insurance policy . , Clients should no ... quotes online is safe and reliable. An insurance brokerage ... are displayed on a single web page, so drivers ... It is now possible to compare online car insurance ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancesavings.biz has ... insurance plans are cheaper during Spring. , ... auto insurance plan. Drivers should make sure they compare ... their vehicles. Clients can learn more about Spring car ... , Auto insurance quotes are becoming more and ...
(Date:4/18/2015)... PITTSBURGH, PA (PRWEB) April 18, 2015 ... store evacuation stretchers in healthcare facilities," said an inventor ... an alternative storage system." , He developed the Slyde ... bathroom doors used in healthcare facilities. It provides convenient ... that there are more stretchers available for patients. ...
Breaking Medicine News(10 mins):Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:A Guide For Avoiding Online Auto Insurance Scams! 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2
... new and efficient strategy, using eggs alone, for creating ... the risk of rejection because the cells are compatible ... mice, the work establishes the principle of using unfertilized ... that are genetically matched to the egg donor at ...
... infected with lymphocytic choriomeningitis virus (LCMV), an infectious agent ... cause severe brain damage in a fetus. ... winter months, when rodents seek shelter in homes, said ... the University of Iowa Roy J. and Lucille A. ...
... Hospital reporting systems may significantly under-report patient safety incidents, ... on bmj.com today//. ,The authors suggest that the ... be sufficient if the NHS is to gather accurate ... safety incidents. ,Patient safety incidents are common ...
... could bankrupt the health system, warn doctors in this week’s ... population is overweight and more than one in five adults ... at high risk of multiple health problems, while the cost ... at up to 9%, and the overall social cost of ...
... past two decades are leading to more definitive diagnoses, ... for patients suffering from a condition called acromegaly. ... for Academic Affairs and director of the Burns and ... medical progress related to the condition that stems from ...
... vaccine, will hold a pride of place in the annals ... to receive certification by the European Medicines Agency, for its ... bird-flu pandemic. , ,This first generation vaccine can ... officially declares a pandemic. ,A second –generation vaccine ...
Cached Medicine News:Health News:Researchers Create Genetically-Matched Embryonic Stem Cells for Transplantation 2Health News:Researchers Create Genetically-Matched Embryonic Stem Cells for Transplantation 3Health News:Pregnant Women Can Minimize Risk Of Rodent-Based Virus 2Health News:Hospitals Miss Most Patient Safety Incidents 2Health News:Obesity Could Bankrupt the Health System, Warn Doctors 2Health News:Options Improving for Patients With Acromegaly and Gigantism 2Health News:Options Improving for Patients With Acromegaly and Gigantism 3
The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
Latex agglutination slide test for the qualitative and semi-quantitative determination of Anti-Streptolysin O (ASO) in human serum...
For the quantitative in vitro determination of IgA in serum and plasma. This product is suitable for use on Hitachi 704, 705, 717, 902, 911 and 912....
Medicine Products: